Results 201 to 210 of about 461,819 (327)

Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Bowel ultrasound (BUS) is increasingly utilised for monitoring inflammatory bowel disease (IBD), a condition with stringent treatment targets to prevent complications. This study assessed the feasibility of BUS in paediatric IBD and its correlation with established monitoring markers.
Zachary Green, Christopher Towriss, James J. Ashton, R. Mark Beattie, Alison Evans, Amar Wahid, Martin Edwards   +6 more
wiley   +1 more source

A narrative review of the ileal pouch in pediatric inflammatory bowel disease and familial adenomatous polyposis

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Ileal pouch‐anal anastomosis is a surgical intervention in patients with medically refractory inflammatory bowel disease and familial adenomatous polyposis syndrome. Reported outcomes in children have been limited by both the retrospective nature and sample size of the investigations.
Anitta Philip, Allyson Wyatt, Jose R. Rodriguez, Brad Pasternak, Lisa McMahon, Kalyani Patel, Richard Kellermayer   +6 more
wiley   +1 more source

The value of fecal calprotectin measured by fluorescent immunochromatography assay in evaluating clinical and endoscopic activity in ulcerative colitis. [PDF]

BMC Gastroenterol
Xu M, Li J, Qian W, Ling F, Chen Y, Li S, Cheng Y, Yu Q, Zhu L.   +8 more
europepmc   +1 more source

Ulcerative Colitis [PDF]

Postgraduate Medical Journal, 1953
openaire   +2 more sources

Prognosis of pediatric‐onset inflammatory bowel disease associated with primary sclerosing cholangitis: A population‐based study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives To assess whether the prognosis of pediatric‐onset inflammatory bowel disease (IBD) is influenced by its association with primary sclerosing cholangitis (PSC) considering medical treatment, bowel resection, risk of cancer, and mortality. Methods A retrospective population‐based study was conducted using data from the EPIMAD Registry,
Marie‐Laura Godet, Hélène Sarter, Frédéric Gottrand, Colin Saoudi, Alexandre Louvet, Mathurin Fumery, Guillaume Savoye, Ariane Leroyer, Corinne Gower‐Rousseau, Delphine Ley, Madeleine Aumar   +10 more
wiley   +1 more source

A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for pediatric use

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Inflammatory bowel disease (IBD) presents before age 20 years in ~25% of patients. Regulatory approvals of IBD medications for pediatric use are often delayed. Nevertheless, many pediatric patients receive medication not approved for pediatric use.
Courtney Rusch, Anthony J. Perkins, Steven J. Steiner, the ImproveCareNow Pediatric IBD Learning Health System   +3 more
wiley   +1 more source

Ulcerative colitis

, 2018
openaire   +1 more source

Cow's milk protein allergy with protein‐losing enteropathy under the scope

JPGN Reports, EarlyView.
ABSTRACT Objectives Cow's milk protein allergy (CMPA) is very frequent in infants. Presentation is variable, and symptoms fluctuate in intensity. Diagnosis can be challenging as it is mostly clinical. In severe cases, patients can present with anasarca secondary to protein‐losing enteropathy (PLE).
Morgane Thorens‐Borgeat, Géraldine Blanchard‐Rohner, Salim Ramadan, Jean‐Christophe Caubet, Laetitia‐Marie Petit, Valerie McLin, Anne‐Laure Rougemont   +6 more
wiley   +1 more source

Impact of biologic induction dose and concomitant drugs on anti‐drug antibody formation in a pediatric IBD cohort with high Hispanic representation

JPGN Reports, EarlyView.
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant, Jenilee Pohle, Robert Tran, Roy Nattiv   +3 more
wiley   +1 more source

Clinical association between inflammatory bowel disease and primary sclerosing cholangitis: what changes after colectomy and liver transplantation? [PDF]

eGastroenterology
Wang S, Farokhian A, Shen B.
europepmc   +1 more source